FindTrial
Sign In

Preoperative Steroid Treatment underwent Ventricular Septal Defect Surgery.

Investigating the impacts of Preoperative Steroid Treatment on Tumor Necrosis Factor-Alpha and Duration of Extubation Time underwent Ventricular Septal Defect Surgery.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
TCTR
Registry ID
TCTR20150930001
Enrollment
Unknown
Registered
2015-09-30
Start date
2015-02-10
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

early extubation on ventricular septal defect patients undergoing cardiopulmonary bypass surgery. Congenital Heart Defect&#44

Interventions

5 micrograms/kg methylprednisolone was injected intravenously 2 hours before the surgery to Group I,no application steroid to the patients in Group II.
Treatment,Treatment
steroid enjected group,no application steroid group

Sponsors

-
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1 Years to 3 Years

Inclusion criteria

Inclusion criteria: ventricular septal defect patients

Exclusion criteria

Exclusion criteria: Complex heart disease or excessive pulmonary hypertension

Design outcomes

Primary

MeasureTime frame
extubation after operation discharged from hospital hours of extubation time—

Secondary

MeasureTime frame
stable cardiovascular status 12 hours later after operation stable tansion arterial—

Countries

Turkey

Contacts

Public ContactHakan Poyrazoglu

Çukurova üniversity

hpoyrazoglu@yahoo.com+905324464734

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026